Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 15.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 263,203 shares of the company's stock after purchasing an additional 36,151 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.14% of Alignment Healthcare worth $2,961,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ALHC. RiverPark Advisors LLC acquired a new stake in Alignment Healthcare during the 4th quarter worth $106,000. Tower Research Capital LLC TRC increased its holdings in Alignment Healthcare by 146.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares in the last quarter. Aigen Investment Management LP acquired a new position in Alignment Healthcare during the fourth quarter worth $129,000. AlphaQuest LLC acquired a new position in shares of Alignment Healthcare during the 4th quarter worth $132,000. Finally, Dark Forest Capital Management LP purchased a new stake in shares of Alignment Healthcare in the fourth quarter valued at about $150,000. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Stock Performance

Shares of ALHC traded down $0.44 during mid-day trading on Monday, hitting $14.78. The stock had a trading volume of 2,728,021 shares, compared to its average volume of 2,018,434. Alignment Healthcare, Inc. has a fifty-two week low of $7.05 and a fifty-two week high of $21.06. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market cap of $2.92 billion, a PE ratio of -19.19 and a beta of 1.22. The company's fifty day simple moving average is $16.70 and its two-hundred day simple moving average is $14.84.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The firm had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. During the same quarter in the previous year, the company posted ($0.25) earnings per share. The firm's revenue was up 47.5% on a year-over-year basis. On average, equities analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on ALHC shares. UBS Group increased their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. Bank of America upped their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a report on Tuesday, March 4th. Stifel Nicolaus raised their price target on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a report on Tuesday, April 8th. William Blair restated an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Finally, Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $17.17.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, insider Robert L. Scavo sold 2,864 shares of the business's stock in a transaction dated Thursday, March 27th. The shares were sold at an average price of $17.89, for a total transaction of $51,236.96. Following the completion of the transaction, the insider now directly owns 702,953 shares of the company's stock, valued at $12,575,829.17. The trade was a 0.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of Alignment Healthcare stock in a transaction on Monday, May 19th. The shares were sold at an average price of $15.28, for a total value of $259,760,000.00. Following the sale, the director now directly owns 44,302,175 shares in the company, valued at $676,937,234. The trade was a 27.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 17,784,649 shares of company stock valued at $273,320,208 in the last quarter. Insiders own 7.00% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.